Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;26(4):1095-1097.
doi: 10.1002/ejhf.3262. Epub 2024 Apr 28.

Association of sodium-glucose cotransporter 2 inhibitors with changes in comprehensive geriatric assessment in elderly diabetic patients with heart failure: Data from MAGIC-HF

Giuseppe Armentaro  1 , Velia Cassano  1 , Valentino Condoleo  1 , Marcello Magurno  1 , Marcello Divino  1 , Carlo Alberto Pastura  1 , Sofia Miceli  1 , Raffaele Maio  1 , Franco Arturi  1   2 , Marta Letizia Hribal  1   2 , Antonio Brunetti  3 , Giorgio Sesti  4 , Giuseppe Massimo Claudio Rosano  5   6 , Angela Sciacqua  1   2
Affiliations

Association of sodium-glucose cotransporter 2 inhibitors with changes in comprehensive geriatric assessment in elderly diabetic patients with heart failure: Data from MAGIC-HF

Giuseppe Armentaro et al. Eur J Heart Fail. 2024 Apr.
No abstract available

PubMed Disclaimer

References

    1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4–131. https://doi.org/10.1002/ejhf.2333
    1. Rodríguez‐Pascual C, Paredes‐Galan E, Vilches‐Moraga A, Ferrero‐Marinez AI, Torrente‐Carballido M, Rodríguez‐Artalejo F. Comprehensive geriatric assessment and 2‐year mortality in elderly patients hospitalized for heart failure. Circ Cardiovasc Qual Outcomes 2014;7:251–258. https://doi.org/10.1161/CIRCOUTCOMES.113.000551
    1. Armentaro G, Condoleo V, Pelaia C, Cassano V, Miceli S, Maio R, et al. Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: A real life analysis. Intern Emerg Med 2023;18:113–125. https://doi.org/10.1007/s11739‐022‐03130‐6
    1. Hierro‐Bujalance C, Infante‐Garcia C, Del Marco A, Herrera M, Carranza‐Naval MJ, Suarez J, et al. Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes. Alzheimers Res Ther 2020;12:40. https://doi.org/10.1186/s13195‐020‐00607‐4
    1. Mone P, Lombardi A, Gambardella J, Pansini A, Macina G, Morgante M, et al. Empagliflozin improves cognitive impairment in frail older adults with type 2 diabetes and heart failure with preserved ejection fraction. Diabetes Care 2022;45:1247–1251. https://doi.org/10.2337/dc21‐2434

Substances

LinkOut - more resources